DEA Investigations
DEA inspections, controlled substance compliance, and Drug Supply Chain Security Act enforcement.
DEA Administrative Hearings: Process and Preparation
How the DEA administrative hearing process works under 21 CFR Part 1316, from the order to show cause through the public interest…
ARCOS Reporting and What DEA Sees About You
ARCOS captures every controlled substance transaction from manufacturer to pharmacy, giving DEA data on your pharmacy before it op…
Buprenorphine Prescribing After the X-Waiver Repeal
The DATA-Waiver requirement for buprenorphine prescribing is gone, but a pharmacist's corresponding responsibility and recordkeepi…
Perpetual Inventory as a Defense Against Shortage Findings
How a continuously reconciled perpetual inventory helps a pharmacist-in-charge document variance before a DEA shortage finding bec…
Refusal to Fill: Balancing Diversion Risk and Patient Care
How a pharmacist-in-charge weighs the corresponding responsibility to prevent diversion under 21 CFR 1306.04 against ADA patient a…
Employee Drug Diversion: Detection and Response
Detection controls, internal investigation steps, and the DEA and state board reporting duties that apply once a pharmacy suspects…
Electronic Prescribing of Controlled Substances Compliance
What DEA's EPCS rule under 21 CFR Part 1311 requires of a pharmacist-in-charge: identity proofing, two-factor authentication, and…
Documenting Red Flag Resolution at the Counter
How pharmacist-in-charge documentation of red flag resolution under DEA's corresponding responsibility standard shows diligence, n…
DEA Form 41 and Controlled Substance Destruction
The DEA Form 41 witness rule, the reverse distributor's 30-day clock, and the documentation a pharmacy needs before destroying con…